Characteristics of new users of aclidinium, aclidinium/formoterol, and other COPD medications in three European countries

Conclusion: AB, AB/FF users showed similar characteristics to those of other LAMA users. Compared with LABA and LABA/ICS users, AB and AB/FF users were older, had a higher frequency of severe COPD, chronic comorbidities, and use of COPD comedications.

Source: European Respiratory Journal - October 28, 2020 Category: Respiratory Medicine Authors: Rebordosa, C., Rubino, A., Witzleb, A. J., Olesen, M., Plana, E., Aguado, J., Saigi, N., Daoud, S. Z., Lei, A., Perez-Gutthann, S., Schink, T., Kristiansen, N. S., Pottegard, A., Rivero-Ferrer, E. Tags: Epidemiology Source Type: research